Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FWHZ7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,597
Award facts
- Contract value 100% obligated
- $10,597.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,597.39 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-count unit of use packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by January 29, 2026. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a prescription immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions, reflecting the Defense Logistics Agency's pharmaceutical procurement needs for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen—through its parent company Cencora, Inc.—to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, medical devices, and specialized healthcare commodities. The DLA Troop Support Medical plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple awards for separate regions, positioning AmerisourceBergen as a critical vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FWHZ7?
SPE2DR26FWHZ7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FWHZ7 worth?
The government has obligated $10,597 on SPE2DR26FWHZ7.
Is contract SPE2DR26FWHZ7 an order under another contract?
Yes. SPE2DR26FWHZ7 is a delivery order under SPE2DR25D3009, an indefinite delivery contract.
Was contract SPE2DR26FWHZ7 competed?
The extent of competition for SPE2DR26FWHZ7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award